Literature DB >> 23101684

Treatment of necrotizing enterocolitis with probiotics.

Kriston Ganguli1, W Allan Walker.   

Abstract

Necrotizing enterocolitis (NEC) is a devastating condition characterized by diffuse intestinal inflammation and necrosis in preterm infants. It is the most common gastrointestinal emergency in the neonatal intensive care unit and is associated with significant morbidity and mortality. Primary risk factors include prematurity and low birth weight. Although the pathogenesis of NEC is complex and not entirely understood, it is known that an interplay between immature intestinal immune responses and the process of bacterial colonization is required for the development of this disease.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23101684     DOI: 10.1016/j.gtc.2012.08.004

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  4 in total

1.  The developmentally regulated fetal enterocyte gene, ZP4, mediates anti-inflammation by the symbiotic bacterial surface factor polysaccharide A on Bacteroides fragilis.

Authors:  Frida Gorreja; Stephen Ta Rush; Dennis L Kasper; Di Meng; W Allan Walker
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-07-17       Impact factor: 4.052

Review 2.  Immunology of pediatric HIV infection.

Authors:  Nicole H Tobin; Grace M Aldrovandi
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

3.  Lactobacillus acidophilus alleviates platelet-activating factor-induced inflammatory responses in human intestinal epithelial cells.

Authors:  Alip Borthakur; Sumit Bhattacharyya; Anoop Kumar; Arivarasu Natarajan Anbazhagan; Joanne K Tobacman; Pradeep K Dudeja
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

4.  Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial.

Authors:  Sanjay Patole; Anthony D Keil; Annie Chang; Elizabeth Nathan; Dorota Doherty; Karen Simmer; Meera Esvaran; Patricia Conway
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.